Ultragenyx Pharmaceutical Inc.
RARE
|
|
| |
|
| Trading Volume | 40,304 |
|
|
57.77 - 31.73 |
| Market Cap Full | $ 4.7B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | -1.4% | -2.4% | -13.5% | -13.1% |
| Q2 | - | -11.9% | 15% | -18.4% |
| Q3 | - | 26.6% | -22.7% | -30.6% |
| Q4 | - | -15% | 37.4% | 11.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.4 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -7.8 | 17.3 | -9.8 | -9.2 | -5.3 | 3.2 | 8.7 | 26.6 | - | - | - | - |
| 2023 | |||||||||||
| -2.2 | -1.9 | -9.9 | 8.9 | 13 | -6.5 | -6.5 | -14.7 | -3.1 | -0.7 | 9.8 | 23.1 |
| 2022 | |||||||||||
| -19.7 | -0.3 | 8.6 | -3.3 | -34.3 | 28.5 | -10.9 | -10.3 | -13.2 | -2.3 | -10.3 | 27.6 |
| 2021 | |||||||||||
| 0.3 | 1.9 | -19.6 | -2.3 | -8.5 | -6.3 | -16.3 | 20.6 | -8.8 | -4.4 | -10.4 | 11.8 |
| 2020 | |||||||||||
| 21.4 | 6.1 | -19.4 | 36 | 13.3 | 14.3 | -0.1 | 10.2 | -4.6 | 22.3 | 18 | 16.8 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -2.3 | -2.2 | -2 | -2.1 |
| Q2 | -2.3 | -2.3 | -1.8 | 0.4 |
| Q3 | -2.2 | -3.5 | -1.1 | -1.1 |
| Q4 | 0 | -2.2 | -1.8 | -0.3 |
| A | -6.81 | -10.1 | -6.7 | -3.1 |